SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT

这是一项开放水平、非比较性、附加治疗、扩展研究，研究对象是先前参加过替加滨HCL癫痫研究的患者。然而，在研究过程中，伴随的抗癫痫药可能会逐渐停用，因此一些患者可能会接受盐酸替加滨单药治疗。本研究可以在美国任何正在进行或曾经进行过替加滨HCL临床研究的地点进行。本研究的目的是确定盐酸替加滨作为慢性治疗癫痫的安全性。

This is an open-lavel, noncomparative, add-on therapy, extension study in patient who have previously participated in a tiagabine HCL epilepsy study. However, during the course of the study concomitant AEDs may be gradually withdrawn so that some patients may be expected to achieve tiagabine HCL monotherapy. This study may be conducted at any site that is conducting or has conducted, tiagabin HCL clinical studies in the United States. The objective of this study is to determine the safety of tiagabine HCl as chronic therapy for epilepsy.